The price of BLTE is predicted to go up -6.4%, based on the high correlation periods with CW. The similarity of these two price pattern on the periods is 90.4%.
BLTE
CW
Down: -6.4%Similarity: 90.4%
BLTE Revenue Forecast
BLTE EPS Forecast
BLTE FAQs
What is BLTE eps forecast for next quarter?
The market consensus for BLTE's eps in the upcoming quarter is projected to be approximately $0.35 USD.
Benchmark raised the firm's price target on Belite Bio to $79 from $57 and keeps a Buy rating on the shares. After speaking to management at a conference last week, the firm revisited its pricing assumptions for Tinlarebant in the treatment of Stargardt disease type 1 and now assumes an average price of $50,000, the analyst tells investors.